Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Applied Materials -- Ignore unavailable to you. Want to Upgrade?

To: Jacob Snyder who wrote (63933)	5/22/2002 10:08:10 AM
From: Cary Salsberg	Read Replies (1) \| Respond to of 70976

RE: "IMO, those who buy the stocks now, are going to get the benefit of all the wealth donated by the Exuberant a couple of years ago." That is a given. Will the "benefit" really benefit, or are the relatively less "Exuberant", today, still betting on a dream. I see little evidence that the fortuitous combination of an aging population and rapidly advancing biotech research will actually produce an engine of profit. On the contrary, for the first time in my lifetime (my dad owned Pfizer in the 50s), the ethical pharmaceutical industry does not seem to be able to continue its growth through internally generated product. It is almost as if the industry has reached an area of diminishing returns just when demographics and research seem to herald a "golden age".